Effect of basal insulin therapy with glargine U300 versus basal bolus insulin therapy in hospitalized patients with type 2 diabetes. Real-world study from India
Background. Basal-bolus insulin therapy is the most widely accepted method of glycemic control in non-critically ill patients with T2DM. In this regimen glargine U100 is the most commonly used basal insulin. American Diabetes Association recommends either basal or basal bolus therapy for patients wi...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Via Medica
2021-05-01
|
| coleção: | Clinical Diabetology |
| Assuntos: | |
| Acesso em linha: | https://journals.viamedica.pl/clinical_diabetology/article/view/71269 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|